Strides Pharma logo

Strides Pharma

Strides Pharma has agreed to a $750,000 class action settlement to resolve claims that its testosterone gel products were contaminated with benzene.

ClosedUnited States-wideClaim status: Closed on September 16, 2026Payout: VariesNo longer claimable

About this settlement

Allegations of benzene contamination in Strides testosterone gel products.

This settlement resolves claims that Strides Pharma's testosterone gel products were contaminated with benzene. Consumers who purchased the product between June 1, 2022, and July 31, 2025, may be eligible for a portion of the $750,000 settlement fund. Proof of purchase, including the NDC number or manufacturer identification, is required.

Who qualifies

  • Consumers who purchased Strides testosterone gel.
  • Purchases made between June 1, 2022, and July 31, 2025.

Varies

Claim status: Closed on September 16, 2026

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

18 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

668 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon